During the past decade, Pharma Medica Research Inc. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharma Medica Research Inc." #1 sponsor was "Teva Pharmaceuticals USA" with 17 trials, followed by "Daewoong Pharmaceutical Co. LTD." with 2 trials sponsored, "Jiangsu Hansoh Pharmaceutical Co., Ltd." with 2 trials sponsored, "Institut für Pharmakologie und Präventive Medizin" with 1 trials sponsored and "J. Uriach and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharma Medica Research Inc." #1 collaborator was "Pharma Medica Research, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pharma Medica Research Inc." are "Healthy" (21 trials), "Healthy Subjects" (2 trials), "Covid19 Vaccine" (1 trials), "Fever" (1 trials) and "Opioid Overdose" (1 trials). Many other conditions were trialed in "Pharma Medica Research Inc." in a lesser frequency.

Most popular intervention types in "Pharma Medica Research Inc." are "Drug" (24 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL" (2 trials), "Dapagliflozin 10 mg tablets" (2 trials), "Farxiga® 10 mg tablets" (2 trials), "Granisetron hydrochloride 1 mg tablets" (2 trials) and "Kytril® 1 mg tablets" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pharma Medica Research Inc." are 20 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Pharma Medica Research Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Pharma Medica Research Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pharma Medica Research Inc., 25 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".